SCHEMBL5267750

SCHEMBL5267750

COC(=O)/C=C\c1n[nH]c2cc(C(F)(F)F)cc(Cc3ccc(Cl)cc3Cl)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR2E1 Q9Y466 1/20 0.37
TBXA2R P21731 1/20 0.36
PTGFR P43088 1/20 0.36
PTGER3 P43115 1/20 0.36
PTGER2 P43116 1/20 0.36
PTGIR P43119 1/20 0.36
PTGDR Q13258 1/20 0.36
ALDH1A1 P00352 3/20 0.36
LMNA P02545 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
P2RX7 Q99572 1/20 0.35
TP53 P04637 2/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
ESR1 P03372 1/20 0.34
PGR P06401 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12693795 0.70 PPARG (0.43) ALDH1A1LMNASMN1; SMN2TP53NPSR1
SCHEMBL1049364 0.70 PPARG (0.43) ALDH1A1LMNASMN1; SMN2TP53NPSR1
SCHEMBL1049898 0.70 NPSR1 (0.44) ALDH1A1LMNASMN1; SMN2TP53NPSR1
SCHEMBL1049365 0.70 PPARG (0.43) ALDH1A1LMNASMN1; SMN2TP53NPSR1
SCHEMBL1049897 0.70 NPSR1 (0.44) ALDH1A1LMNASMN1; SMN2TP53NPSR1
SCHEMBL997788 0.66 ALPL (0.39) ALDH1A1LMNASMN1; SMN2P2RX7HPGD
SCHEMBL998544 0.65 KDM4E (0.45) TBXA2RPTGFRPTGER3PTGER2PTGIR
SCHEMBL4092629 0.65 LMNA (0.41) ALDH1A1LMNASMN1; SMN2TP53NPSR1
SCHEMBL1048828 0.65 LMNA (0.41) ALDH1A1LMNASMN1; SMN2TP53NPSR1
SCHEMBL997395 0.64 NR1H2 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP disclosed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO disclosed